So Mi Kim

So Mi Kim

Auto-generated profile, based on publicly available information

So Mi Kim

Division of Nephrology, Department of Internal Medicine, Dankook University Hospital, Dankook University College of Medicine, Cheonan, Republic of Korea

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 November 2020 in The Korean Journal of Internal Medicine
Verified
Journal Article
Open access
PDF file
SKSo Mi Kim
So Mi Kim
ISIl Han Song
Il Han Song
Gut microorganisms play critical roles in both maintaining host homeostasis and the development of diverse diseases. Gut dysbiosis, an alteration of the composition and function of gut microorganisms, is commonly seen in patients with chronic kidney disease (CKD). CKD itself contributes to a disruption of the symbiotic relationship between the gut microbiota and the host, while the resulting gut dysbiosis may play a part in stage progression of CKD. This bidirectional relationship supports the concept that the gut microbiota is considered a novel focus for the pathogenesis and management of CKD. This article examines the interaction between the gut microbiota and the kidney, the mutual effects of dysbiosis and CKD, and possible treatment options to restore gut eubiosis, and reduce CKD progression and its related complications.


31 December 2017 in Kidney Research and Clinical Practice
Verified
Journal Article
Open access
PDF file
JRJiyoung Rhee
Jiyoung Rhee
JKJung Mi Kwon
Jung Mi Kwon
SHSang Hoon Han
Sang Hoon Han
SKSun Hyung Kim
Sun Hyung Kim
CPChang Hyun Park
Chang Hyun Park
SKSo Mi Kim
So Mi Kim
Jiyoung Rhee, Jung Mi Kwon, Sang Hoon Han, Sun Hyung Kim, Chang Hyun Park, Ji Hyeon Jeon, Jong Tae Cho, Eun Kyoung Lee, So Mi Kim. Kidney Res Clin Pract 2017;36:342-8. https://doi.org/10.23876/j.krcp.2017.36.4.342

20 September 2018 in BMC Nephrology
Verified
Journal Article
Open access
PDF file
SBseung don baek
seung don baek
JKJae-Young Kang
Jae-Young Kang
HYHoon Yu
Hoon Yu
SSSeulgi Shin
Seulgi Shin
HPHyang-Sook Park
Hyang-Sook Park
JCJai Won Chang
Jai Won Chang
Evidence suggests that alkaline phosphatase attenuates inflammatory response in sepsis by lipopolysaccharide detoxification and adenosine triphosphate dephosphorylation. We sought to determine changes in alkaline phosphatase (AP) activity during septic acute kidney injury (AKI) and clinical parameters associated with AP activity. In this retrospective study, we investigated baseline (when initiating CRRT) and follow-up AP activity on day 3, and associated outcomes in patients who underwent continuous renal replacement therapy (CRRT) due to septic AKI. We analyzed the baseline AP activity of 155 patients and day 3 AP activity in 123 patients. Baseline AP activity was not associated with renal or inflammatory biomarkers, or outcomes. It did not significantly differ between the 75 survivors and 80 non-survivors (p = 0.155). AP activity was higher on day 3 than at baseline (105 U/L [interquartile range, 79–156] vs 90 U/L [interquartile range, 59–133]). In particular, liver and bone isoforms increased significantly (p < 0.05), but intestine isoforms did not reach statistical significance (p = 0.367). In addition, day 3 AP activity showed a weak correlation with length of ICU stay (r = 0.213, p = 0.018) and length of hospital stay (r = 0.216, p = 0.017), but not with survival (r = − 0.035, p = 0.698). Endogenous AP activity significantly increased in patients with septic AKI. However, neither baseline nor follow-up AP activity was associated with survival.

1 October 2023 in The Journal of Rheumatology
Verified
Journal Article
Open access
PDF file
HKHyeok Chan Kwon
Hyeok Chan Kwon
MKMi Il Kang
Mi Il Kang
SKSo Mi Kim
So Mi Kim
Objective: Methotrexate (MTX) is an anchor drug for most patients with rheumatoid arthritis (RA); however, its use may be limited depending on renal function. Therefore, this study aimed to examine the discrepancy in the estimated glomerular filtration rate (eGFR) using conventional serum creatinine (SCr)-, cystatin C-, and MTX-associated toxicities in patients with RA.Methods: In total, 436 patients were enrolled, and eGFR was evaluated using the Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI) equation based on both cystatin C and SCr levels. The CKD and MTX dosing stages were classified according to eGFR. MTX-associated toxicities were also evaluated.Results: The mean eGFR using CKD-EPI cystatin C (CKD-EPIcys) was 89.44 mL/min/1.73 m2, lower than the eGFR using CKD-EPI SCr (CKD-EPISCr) of 95.55 mL/min/1.73 m2. After converting eGFR to CKD-EPIcysby CKD-EPISCr, 29.8% of patients were reclassified to a higher stage according to the Kidney Disease: Improving Global Outcomes CKD stage. Also, according to the MTX guidelines, 6.4% of the group with an eGFR > 50 mL/min/1.73 m2were reclassified to eGFR 10-50 mL/1.73 m2, requiring dose adjustment. The incidence of MTX-associated toxicities, such as anemia, leukopenia, and nephrotoxicity, was significantly higher in the CKD stage-changed group than in the nonstage-changed group.Conclusion: Our results showed that eGFR based on SCr was overestimated compared with eGFR based on cystatin C. In addition, we demonstrated that MTX-associated toxicities were significantly increased in the group with a changed stage when the eGFR was converted from CKD-EPISCrto CKD-EPIcys.

1 January 2015 in The Korean Journal of Medicine
Verified
Journal Article
Open access
PDF file
MKMiyeon Kim
Miyeon Kim
HKHyun Woo Kim
Hyun Woo Kim
JKJi Young Kim
Ji Young Kim
JJJinho Jeong
Jinho Jeong
EPEun-Jung Park
Eun-Jung Park
SKSo Mi Kim
So Mi Kim